Puma Biotechnology Inc (PBYI)

SG&A Expenses

$17.55M

Quarterly · Period ending: · USD

PBYI logo

PBYI SG&A Expenses

Latest reported$17.55M
PBYI Quarterly SG&A Expenses ($0.00 → $17.55M)
High-resolution chart · PNG

PBYI sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Puma Biotechnology Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
17,547,000
18,423,000
18,379,000
17,030,000
18,409,000
17,391,000
17,020,000
16,867,000
24,972,000
21,750,000
20,184,000
22,176,000
23,948,000
22,486,000
25,039,000
23,961,000
20,576,000
20,402,000
22,462,000
26,084,000
39,410,000
28,238,000
28,606,000
29,598,000
29,347,000
30,937,000
30,074,000
31,400,000
33,527,000
45,500,000
41,000,000
28,500,000
40,135,000
36,602,000
30,900,000
32,489,000
24,929,000
18,401,000
16,500,000
14,022,000
12,265,000
11,039,000
9,600,000
8,809,000
5,532,000
7,871,000
8,100,000
3,867,000
3,904,000
3,525,000
2,983,000
2,263,000
2,267,000
2,300,000
13,800,000
8,025,241
1,701,877
1,234,626
-10,195
333,766
3,312
6,883
5,638
3,203
2,438
4,697
3,312
3,308
4,209
6,007
2,249
3,968
3,375
4,491
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.